Clinical Trial: Efficacy and Safety of High-Dose Oral 35 kDa Hyaluronan for Aesthetic Improvement

U.S., May 14 -- ClinicalTrials.gov registry received information related to the study (NCT07583108) titled 'Efficacy and Safety of High-Dose Oral 35 kDa Hyaluronan for Aesthetic Improvement' on April 28.

Brief Summary: This is a prospective, single-arm, open-label, pilot clinical study to evaluate the efficacy and safety of high-dose oral 70 kDa hyaluronan (HA35) for aesthetic improvement. Eligible participants will receive 5 g oral HA35 once daily on an empty stomach for 40 consecutive days. The primary objectives are to assess changes in facial and body subcutaneous fullness, inflammatory erythema, facial vitality, and body weight. Safety, gastrointestinal tolerability, and additional exploratory outcomes will be evaluated throughout the...